Related Experiment Video
Updated: Jun 22, 2026

Chromatin Immunoprecipitation (ChIP) to Assay Dynamic Histone Modification in Activated Gene Expression in Human Cells
Published on: July 29, 2010
Acetylation and activation of STAT3 mediated by nuclear translocation of CD44
Jia-Lin Lee1, Mei-Jung Wang, Jeou-Yuan Chen
1Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, Republic of China.
Abstract:
Expression of the type I transmembrane glycoprotein CD44 has recently been recognized as a signature for cancer stem cells. In this study, we demonstrate that CD44, once engaged, is internalized and translocated to the nucleus, where it binds to various promoters, including that of cyclin D1, leading to cell fate change through transcriptional reprogramming. In regulating cyclin D1 expression, the internalized CD44 forms a complex with STAT3 and p300 (acetyltransferase), eliciting STAT3 acetylation at lysine 685 and dimer formation in a cytokine- and growth factor-independent manner. A bipartite nuclear localization signal (NLS) was mapped to the cytoplasmic tail of CD44, which mediates its nuclear translocation. Expression of CD44(NLS) mutant sequesters STAT3 in cytosol. In the nucleus, the acetylated STAT3 dimer remains associated with CD44 and binds to the cyclin D1 promoter, leading to increased cyclin D1 expression and cell proliferation. This study describes a novel function for CD44 in transcriptional modulation through nuclear translocation of the internalized CD44 and complex formation with transcription factors.
Insights
Cancer stem cell marker CD44 translocates to the nucleus, reprogramming cell fate by binding promoters like cyclin D1. This novel mechanism involves CD44 complexing with STAT3 and p300 to enhance cyclin D1 expression and cell proliferation.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- CD44, a type I transmembrane glycoprotein, is a recognized marker for cancer stem cells.
- CD44's role in cancer progression and its intracellular functions are areas of ongoing investigation.
Purpose of the Study:
- To elucidate the novel function of CD44 in transcriptional regulation.
- To investigate the mechanism of CD44 internalization, nuclear translocation, and its impact on gene expression.
Main Methods:
- Utilized techniques to track CD44 internalization and nuclear localization.
- Mapped the bipartite nuclear localization signal (NLS) in the CD44 cytoplasmic tail.
- Investigated the interaction of CD44 with STAT3 and p300 using biochemical assays.
- Analyzed the effect of CD44 on cyclin D1 promoter activity and gene expression.
Main Results:
- Engaged CD44 is internalized and translocated to the nucleus.
- Nuclear CD44 binds to promoters, including cyclin D1, mediating transcriptional reprogramming.
- Internalized CD44 forms a complex with STAT3 and p300, inducing STAT3 acetylation and dimerization independently of external signals.
- A bipartite NLS in CD44's cytoplasmic tail directs its nuclear translocation; a CD44(NLS) mutant retains STAT3 in the cytosol.
- Acetylated STAT3 dimers, associated with CD44, bind the cyclin D1 promoter, increasing its expression and promoting cell proliferation.
Conclusions:
- CD44 possesses a novel function in transcriptional modulation via nuclear translocation.
- The CD44-STAT3-p300 complex regulates cyclin D1 expression, driving cell proliferation.
- This pathway represents a new mechanism by which cancer stem cell markers influence tumor progression.
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
TGF - β Signaling Pathway
MAPK Signaling Cascades
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...

